Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
: 25 26 25 26 O
for 27 30 27 30 O
infants 31 38 31 38 O
less 39 43 39 43 O
than 44 48 44 48 O
or 49 51 49 51 O
equal 52 57 52 57 O
to 58 60 58 60 O
24 61 63 61 63 O
hours 64 69 64 69 O
old 70 73 70 73 O
, 73 74 73 74 O
less 75 79 75 79 O
than 80 84 80 84 O
4,000 85 90 85 90 B-upper_bound
cells 91 96 91 96 I-upper_bound
/ 96 97 96 97 I-upper_bound
mm^3 97 101 97 101 I-upper_bound
; 101 102 101 102 O
for 103 106 103 106 O
infants 107 114 107 114 O
greater 115 122 115 122 O
than 123 127 123 127 O
24 128 130 128 130 O
hours 131 136 131 136 O
old 137 140 137 140 O
, 140 141 140 141 O
less 142 146 142 146 O
than 147 151 147 151 O
1,250 152 157 152 157 B-upper_bound
cells 158 163 158 163 I-upper_bound
/ 163 164 163 164 I-upper_bound
mm^3 164 168 164 168 I-upper_bound

Allowable 0 9 169 178 O
infant 10 16 179 185 O
age 17 20 186 189 B-age
at 21 23 190 192 O
the 24 27 193 196 O
time 28 32 197 201 O
of 33 35 202 204 O
enrollment 36 46 205 215 O
is 47 49 216 218 O
dependent 50 59 219 228 O
on 60 62 229 231 O
the 63 66 232 235 O
Dose 67 71 236 240 O
Group 72 77 241 246 O
and 78 81 247 250 O
Cohort 82 88 251 257 O

Any 0 3 258 261 O
requirement 4 15 262 273 O
for 16 19 274 277 O
supplemental 20 32 278 290 B-treatment
oxygen 33 39 291 297 I-treatment
beyond 40 46 298 304 O
24 47 49 305 307 B-upper_bound
hours 50 55 308 313 I-upper_bound
of 56 58 314 316 O
life 59 63 317 321 O
or 64 66 322 324 O
requiring 67 76 325 334 O
supplemental 77 89 335 347 O
oxygen 90 96 348 354 O
at 97 99 355 357 O
the 100 103 358 361 O
time 104 108 362 366 O
of 109 111 367 369 O
the 112 115 370 373 O
VRC01 116 121 374 379 B-treatment
, 121 122 379 380 O
VRC01LS 123 130 381 388 B-treatment
, 130 131 388 389 O
or 132 134 390 392 O
VRC07 135 140 393 398 B-treatment
- 140 141 398 399 O
523LS 141 146 399 404 B-treatment
dose 147 151 405 409 O

At 0 2 410 412 O
increased 3 12 413 422 O
risk 13 17 423 427 O
of 18 20 428 430 O
HIV 21 24 431 434 B-chronic_disease
acquisition 25 36 435 446 O
defined 37 44 447 454 O
as 45 47 455 457 O
documentation 48 61 458 471 O
of 62 64 472 474 O
one 65 68 475 478 B-lower_bound
or 69 71 479 481 O
more 72 76 482 486 O
of 77 79 487 489 O
the 80 83 490 493 O
following 84 93 494 503 O
risk 94 98 504 508 O
factors 99 106 509 516 O

Birth 0 5 517 522 B-clinical_variable
weight 6 12 523 529 I-clinical_variable
greater 13 20 530 537 O
than 21 25 538 542 O
or 26 28 543 545 O
equal 29 34 546 551 O
to 35 37 552 554 O
2.0 38 41 555 558 B-lower_bound
kg 42 44 559 561 I-lower_bound

Born 0 4 562 566 O
to 5 7 567 569 O
an 8 10 570 572 O
HIV-1 11 16 573 578 B-chronic_disease
- 16 17 578 579 O
infected 17 25 579 587 O
woman 26 31 588 593 B-gender
who 32 35 594 597 O
meets 36 41 598 603 O
all 42 45 604 607 O
maternal 46 54 608 616 O
inclusion 55 64 617 626 O
/ 64 65 626 627 O
exclusion 65 74 627 636 O
criteria 75 83 637 645 O
listed 84 90 646 652 O
above 91 96 653 658 O

Documentation 0 13 659 672 O
of 14 16 673 675 O
HIV 17 20 676 679 B-chronic_disease
infection 21 30 680 689 I-chronic_disease

Documentation 0 13 690 703 O
of 14 16 704 706 O
HIV-1 17 22 707 712 B-chronic_disease
infection 23 32 713 722 I-chronic_disease
is 33 35 723 725 O
defined 36 43 726 733 O
as 44 46 734 736 O
positive 47 55 737 745 O
results 56 63 746 753 O
from 64 68 754 758 O
two 69 72 759 762 O
samples 73 80 763 770 O
collected 81 90 771 780 O
at 91 93 781 783 O
different 94 103 784 793 O
time 104 108 794 798 O
points 109 115 799 805 O
. 115 116 805 806 O
All 117 120 807 810 O
samples 121 128 811 818 O
tested 129 135 819 825 O
must 136 140 826 830 O
be 141 143 831 833 O
whole 144 149 834 839 O
blood 150 155 840 845 O
, 155 156 845 846 O
serum 157 162 847 852 O
, 162 163 852 853 O
or 164 166 854 856 O
plasma 167 173 857 863 O
. 173 174 863 864 O
For 175 178 865 868 O
this 179 183 869 873 O
protocol 184 192 874 882 O
, 192 193 882 883 O
the 194 197 884 887 O
results 198 205 888 895 O
for 206 209 896 899 O
sample 210 216 900 906 O
# 217 218 907 908 O
2 218 219 908 909 O
may 220 223 910 913 O
be 224 226 914 916 O
pending 227 234 917 924 O
at 235 237 925 927 O
the 238 241 928 931 O
time 242 246 932 936 O
of 247 249 937 939 O
enrollment 250 260 940 950 O
. 260 261 950 951 O
Results 262 269 952 959 O
documented 270 280 960 970 O
in 281 283 971 973 O
the 284 287 974 977 O
clinical 288 296 978 986 O
record 297 303 987 993 O
from 304 308 994 998 O
past 309 313 999 1003 O
testing 314 321 1004 1011 O
may 322 325 1012 1015 O
be 326 328 1016 1018 O
used 329 333 1019 1023 O
to 334 336 1024 1026 O
satisfy 337 344 1027 1034 O
the 345 348 1035 1038 O
criteria 349 357 1039 1047 O
for 358 361 1048 1051 O
documentation 362 375 1052 1065 O
of 376 378 1066 1068 O
HIV-1 379 384 1069 1074 O
infection 385 394 1075 1084 O
. 394 395 1084 1085 O
More 396 400 1086 1090 O
information 401 412 1091 1102 O
on 413 415 1103 1105 O
this 416 420 1106 1110 O
criterion 421 430 1111 1120 O
can 431 434 1121 1124 O
be 435 437 1125 1127 O
found 438 443 1128 1133 O
in 444 446 1134 1136 O
the 447 450 1137 1140 O
protocol 451 459 1141 1149 O

Documented 0 10 1150 1160 O
or 11 13 1161 1163 O
suspected 14 23 1164 1173 O
serious 24 31 1174 1181 B-chronic_disease
medical 32 39 1182 1189 I-chronic_disease
illness 40 47 1190 1197 I-chronic_disease
or 48 50 1198 1200 O
immediate 51 60 1201 1210 O
life 61 65 1211 1215 O
- 65 66 1215 1216 O
threatening 66 77 1216 1227 O
condition 78 87 1228 1237 O
( 88 89 1238 1239 O
other 89 94 1239 1244 O
than 95 99 1245 1249 O
HIV 100 103 1250 1253 B-chronic_disease
infection 104 113 1254 1263 O
) 113 114 1263 1264 O
in 115 117 1265 1267 O
the 118 121 1268 1271 O
mother 122 128 1272 1278 O
that 129 133 1279 1283 O
may 134 137 1284 1287 O
interfere 138 147 1288 1297 O
with 148 152 1298 1302 O
the 153 156 1303 1306 O
ability 157 164 1307 1314 O
to 165 167 1315 1317 O
complete 168 176 1318 1326 O
study 177 182 1327 1332 O
requirements 183 195 1333 1345 O
, 195 196 1345 1346 O
as 197 199 1347 1349 O
judged 200 206 1350 1356 O
by 207 209 1357 1359 O
the 210 213 1360 1363 O
examining 214 223 1364 1373 O
clinician 224 233 1374 1383 O

Documented 0 10 1384 1394 O
or 11 13 1395 1397 O
suspected 14 23 1398 1407 O
serious 24 31 1408 1415 O
medical 32 39 1416 1423 B-chronic_disease
illness 40 47 1424 1431 I-chronic_disease
, 47 48 1431 1432 O
serious 49 56 1433 1440 B-chronic_disease
congenital 57 67 1441 1451 I-chronic_disease
anomaly 68 75 1452 1459 I-chronic_disease
, 75 76 1459 1460 O
or 77 79 1461 1463 O
immediate 80 89 1464 1473 O
life 90 94 1474 1478 B-chronic_disease
- 94 95 1478 1479 I-chronic_disease
threatening 95 106 1479 1490 I-chronic_disease
condition 107 116 1491 1500 I-chronic_disease
in 117 119 1501 1503 O
the 120 123 1504 1507 O
infant 124 130 1508 1514 O
that 131 135 1515 1519 O
may 136 139 1520 1523 O
interfere 140 149 1524 1533 O
with 150 154 1534 1538 O
the 155 158 1539 1542 O
ability 159 166 1543 1550 O
to 167 169 1551 1553 O
complete 170 178 1554 1562 O
study 179 184 1563 1568 O
requirements 185 197 1569 1581 O
, 197 198 1581 1582 O
as 199 201 1583 1585 O
judged 202 208 1586 1592 O
by 209 211 1593 1595 O
the 212 215 1596 1599 O
examining 216 225 1600 1609 O
clinician 226 235 1610 1619 O

Dose 0 4 1620 1624 O
Groups 5 11 1625 1631 O
4 12 13 1632 1633 O
and 14 17 1634 1637 O
5 18 19 1638 1639 O
( 20 21 1640 1641 O
Cohort 21 27 1641 1647 O
1 28 29 1648 1649 O
): 29 31 1649 1651 O
Less 32 36 1652 1656 O
than 37 41 1657 1661 O
72 42 44 1662 1664 B-upper_bound
hours 45 50 1665 1670 I-upper_bound
of 51 53 1671 1673 O
age 54 57 1674 1677 B-age
, 57 58 1677 1678 O
and 59 62 1679 1682 O
anticipated 63 74 1683 1694 O
availability 75 87 1695 1707 O
to 88 90 1708 1710 O
receive 91 98 1711 1718 O
VRC01LS 99 106 1719 1726 B-treatment
or 107 109 1727 1729 O
VRC07 110 115 1730 1735 B-treatment
- 115 116 1735 1736 I-treatment
523LS 116 121 1736 1741 I-treatment
immunization 122 134 1742 1754 O
at 135 137 1755 1757 O
less 138 142 1758 1762 O
than 143 147 1763 1767 O
72 148 150 1768 1770 B-upper_bound
hours 151 156 1771 1776 I-upper_bound
after 157 162 1777 1782 I-upper_bound
birth 163 168 1783 1788 O

Dose 0 4 1789 1793 O
Groups 5 11 1794 1800 O
4 12 13 1801 1802 O
and 14 17 1803 1806 O
5 18 19 1807 1808 O
( 20 21 1809 1810 O
Cohort 21 27 1810 1816 O
2 28 29 1817 1818 O
): 29 31 1818 1820 O
Less 32 36 1821 1825 O
than 37 41 1826 1830 O
or 42 44 1831 1833 O
equal 45 50 1834 1839 O
to 51 53 1840 1842 O
5 54 55 1843 1844 O
days 56 60 1845 1849 O
of 61 63 1850 1852 O
age 64 67 1853 1856 B-age
, 67 68 1856 1857 O
and 69 72 1858 1861 O
anticipated 73 84 1862 1873 O
availability 85 97 1874 1886 O
to 98 100 1887 1889 O
receive 101 108 1890 1897 O
VRC01LS 109 116 1898 1905 B-treatment
or 117 119 1906 1908 O
VRC07 120 125 1909 1914 B-treatment
- 125 126 1914 1915 I-treatment
523LS 126 131 1915 1920 I-treatment
immunization 132 144 1921 1933 I-treatment
no 145 147 1934 1936 O
more 148 152 1937 1941 O
than 153 157 1942 1946 O
5 158 159 1947 1948 O
days 160 164 1949 1953 O
after 165 170 1954 1959 O
birth 171 176 1960 1965 O

Gestational 0 11 1966 1977 B-clinical_variable
age 12 15 1978 1981 I-clinical_variable
, 15 16 1981 1982 O
by 17 19 1983 1985 O
best 20 24 1986 1990 O
obstetrical 25 36 1991 2002 O
, 36 37 2002 2003 O
ultrasound 38 48 2004 2014 O
, 48 49 2014 2015 O
or 50 52 2016 2018 O
infant 53 59 2019 2025 O
exam 60 64 2026 2030 O
, 64 65 2030 2031 O
greater 66 73 2032 2039 O
than 74 78 2040 2044 O
or 79 81 2045 2047 O
equal 82 87 2048 2053 O
to 88 90 2054 2056 O
36 91 93 2057 2059 B-lower_bound
weeks 94 99 2060 2065 I-lower_bound

Greater 0 7 2066 2073 O
than 8 12 2074 2078 O
or 13 15 2079 2081 O
equal 16 21 2082 2087 O
to 22 24 2088 2090 O
18 25 27 2091 2093 B-lower_bound
years 28 33 2094 2099 I-lower_bound
of 34 36 2100 2102 O
age 37 40 2103 2106 B-age

Hemoglobin 0 10 2107 2117 B-clinical_variable
less 11 15 2118 2122 O
than 16 20 2123 2127 O
12.0 21 25 2128 2132 B-upper_bound
g 26 27 2133 2134 I-upper_bound
/ 27 28 2134 2135 I-upper_bound
dL 28 30 2135 2137 I-upper_bound

Mother 0 6 2138 2144 O
received 7 15 2145 2153 O
no 16 18 2154 2156 O
antiretroviral 19 33 2157 2171 B-treatment
therapy 34 41 2172 2179 I-treatment
( 42 43 2180 2181 I-treatment
ART 43 46 2181 2184 I-treatment
) 46 47 2184 2185 I-treatment
during 48 54 2186 2192 O
pregnancy 55 64 2193 2202 B-pregnancy

Mother 0 6 2203 2209 O
with 7 11 2210 2214 O
any 12 15 2215 2218 O
detectable 16 26 2219 2229 O
viral 27 32 2230 2235 O
replication 33 44 2236 2247 O
( 45 46 2248 2249 O
HIV 46 49 2249 2252 B-chronic_disease
RNA 50 53 2253 2256 B-clinical_variable
above 54 59 2257 2262 O
the 60 63 2263 2266 O
limit 64 69 2267 2272 O
of 70 72 2273 2275 O
detection 73 82 2276 2285 O
) 82 83 2285 2286 O
at 84 86 2287 2289 O
last 87 91 2290 2294 O
measurement 92 103 2295 2306 O
prior 104 109 2307 2312 O
to 110 112 2313 2315 O
delivery 113 121 2316 2324 O
determined 122 132 2325 2335 O
within 133 139 2336 2342 O
30 140 142 2343 2345 B-upper_bound
days 143 147 2346 2350 I-upper_bound
of 148 150 2351 2353 O
delivery 151 159 2354 2362 O

Mother 0 6 2363 2369 O
with 7 11 2370 2374 O
documented 12 22 2375 2385 O
* 22 23 2385 2386 O
2 24 25 2387 2388 O
- 25 26 2388 2389 O
class 26 31 2389 2394 O
resistant 32 41 2395 2404 O
HIV 42 45 2405 2408 B-chronic_disease
infection 46 55 2409 2418 I-chronic_disease
, 55 56 2418 2419 O
which 57 62 2420 2425 O
may 63 66 2426 2429 O
include 67 74 2430 2437 O
historical 75 85 2438 2448 O
documentation 86 99 2449 2462 O
of 100 102 2463 2465 O
lack 103 107 2466 2470 O
of 108 110 2471 2473 O
response 111 119 2474 2482 O

Platelet 0 8 2483 2491 B-clinical_variable
count 9 14 2492 2497 I-clinical_variable
less 15 19 2498 2502 O
than 20 24 2503 2507 O
100,000 25 32 2508 2515 B-upper_bound
cells 33 38 2516 2521 I-upper_bound
/ 38 39 2521 2522 I-upper_bound
mm^3 39 43 2522 2526 I-upper_bound

Prior 0 5 2527 2532 O
participation 6 19 2533 2546 O
in 20 22 2547 2549 O
any 23 26 2550 2553 O
HIV-1 27 32 2554 2559 B-treatment
vaccine 33 40 2560 2567 I-treatment
trial 41 46 2568 2573 I-treatment

Prolonged 0 9 2574 2583 O
rupture 10 17 2584 2591 O
of 18 20 2592 2594 O
membranes 21 30 2595 2604 O
( 31 32 2605 2606 O
greater 32 39 2606 2613 O
than 40 44 2614 2618 O
12 45 47 2619 2621 B-lower_bound
hours 48 53 2622 2627 I-lower_bound
) 53 54 2627 2628 O

Receipt 0 7 2629 2636 O
of 8 10 2637 2639 O
any 11 14 2640 2643 O
other 15 20 2644 2649 O
active 21 27 2650 2656 O
or 28 30 2657 2659 O
passive 31 38 2660 2667 O
HIV 39 42 2668 2671 B-treatment
immunotherapy 43 56 2672 2685 I-treatment
or 57 59 2686 2688 O
investigational 60 75 2689 2704 B-treatment
product 76 83 2705 2712 I-treatment
during 84 90 2713 2719 O
this 91 95 2720 2724 O
pregnancy 96 105 2725 2734 B-pregnancy

Receipt 0 7 2735 2742 O
of 8 10 2743 2745 O
any 11 14 2746 2749 O
other 15 20 2750 2755 O
active 21 27 2756 2762 B-treatment
or 28 30 2763 2765 I-treatment
passive 31 38 2766 2773 I-treatment
HIV 39 42 2774 2777 I-treatment
immunotherapy 43 56 2778 2791 I-treatment
or 57 59 2792 2794 O
investigational 60 75 2795 2810 B-treatment
product 76 83 2811 2818 I-treatment
other 84 89 2819 2824 O
than 90 94 2825 2829 O
the 95 98 2830 2833 O
study 99 104 2834 2839 O
vaccine 105 112 2840 2847 B-treatment

Receipt 0 7 2848 2855 O
of 8 10 2856 2858 O
or 11 13 2859 2861 O
anticipated 14 25 2862 2873 O
need 26 30 2874 2878 O
for 31 34 2879 2882 O
blood 35 40 2883 2888 O
products 41 49 2889 2897 O
, 49 50 2897 2898 O
immunoglobulin 51 65 2899 2913 B-treatment
, 65 66 2913 2914 O
or 67 69 2915 2917 O
immunosuppressive 70 87 2918 2935 B-treatment
therapy 88 95 2936 2943 I-treatment
. 95 96 2943 2944 O
This 97 101 2945 2949 O
includes 102 110 2950 2958 O
infants 111 118 2959 2966 O
who 119 122 2967 2970 O
require 123 130 2971 2978 O
hepatitis 131 140 2979 2988 B-treatment
B 141 142 2989 2990 I-treatment
immunoglobulin 143 157 2991 3005 I-treatment
( 158 159 3006 3007 I-treatment
HBIG 159 163 3007 3011 I-treatment
) 163 164 3011 3012 I-treatment
but 165 168 3013 3016 O
does 169 173 3017 3021 O
not 174 177 3022 3025 O
require 178 185 3026 3033 O
exclusion 186 195 3034 3043 O
of 196 198 3044 3046 O
infants 199 206 3047 3054 O
who 207 210 3055 3058 O
receive 211 218 3059 3066 O
hepatitis 219 228 3067 3076 B-treatment
B 229 230 3077 3078 I-treatment
vaccine 231 238 3079 3086 I-treatment
in 239 241 3087 3089 O
the 242 245 3090 3093 O
newborn 246 253 3094 3101 O
period 254 260 3102 3108 O

Serum 0 5 3109 3114 B-clinical_variable
glutamic 6 14 3115 3123 I-clinical_variable
pyruvic 15 22 3124 3131 I-clinical_variable
transaminase 23 35 3132 3144 I-clinical_variable
( 36 37 3145 3146 I-clinical_variable
SGPT 37 41 3146 3150 I-clinical_variable
) 41 42 3150 3151 I-clinical_variable
( 43 44 3152 3153 B-clinical_variable
alanine 44 51 3153 3160 I-clinical_variable
aminotransferase 52 68 3161 3177 I-clinical_variable
[ 69 70 3178 3179 I-clinical_variable
ALT 70 73 3179 3182 I-clinical_variable
] 73 74 3182 3183 I-clinical_variable
) 74 75 3183 3184 I-clinical_variable
greater 76 83 3185 3192 O
than 84 88 3193 3197 O
or 89 91 3198 3200 O
equal 92 97 3201 3206 O
to 98 100 3207 3209 O
1.25 101 105 3210 3214 B-lower_bound
times 106 111 3215 3220 I-lower_bound
upper 112 117 3221 3226 I-lower_bound
limit 118 123 3227 3232 I-lower_bound
of 124 126 3233 3235 O
age 127 130 3236 3239 B-age
adjusted 131 139 3240 3248 O
normal 140 146 3249 3255 O

Women 0 5 3256 3261 B-gender
who 6 9 3262 3265 O
have 10 14 3266 3270 O
a 15 16 3271 3272 O
documented 17 27 3273 3283 O
history 28 35 3284 3291 O
of 36 38 3292 3294 O
virologic 39 48 3295 3304 O
failure 49 56 3305 3312 O
while 57 62 3313 3318 O
on 63 65 3319 3321 O
non 66 69 3322 3325 B-treatment
- 69 70 3325 3326 I-treatment
nucleoside 70 80 3326 3336 I-treatment
reverse 81 88 3337 3344 I-treatment
transcriptase 89 102 3345 3358 I-treatment
inhibitors 103 113 3359 3369 I-treatment
( 114 115 3370 3371 I-treatment
NNRTIs 115 121 3371 3377 I-treatment
) 121 122 3377 3378 I-treatment
but 123 126 3379 3382 O
who 127 130 3383 3386 O
had 131 134 3387 3390 O
no 135 137 3391 3393 O
resistance 138 148 3394 3404 O
testing 149 156 3405 3412 O
at 157 159 3413 3415 O
the 160 163 3416 3419 O
time 164 168 3420 3424 O
of 169 171 3425 3427 O
viral 172 177 3428 3433 O
failure 178 185 3434 3441 O
will 186 190 3442 3446 O
be 191 193 3447 3449 O
considered 194 204 3450 3460 O
to 205 207 3461 3463 O
have 208 212 3464 3468 O
NNRTI 213 218 3469 3474 O
- 218 219 3474 3475 O
documented 219 229 3475 3485 O
resistance 230 240 3486 3496 O

mother 0 6 3497 3503 O
began 7 12 3504 3509 O
or 13 15 3510 3512 O
reinitiated 16 27 3513 3524 O
ART 28 31 3525 3528 B-treatment
( 32 33 3529 3530 O
after 33 38 3530 3535 O
an 39 41 3536 3538 O
interruption 42 54 3539 3551 O
of 55 57 3552 3554 O
greater 58 65 3555 3562 O
than 66 70 3563 3567 O
14 71 73 3568 3570 B-lower_bound
days 74 78 3571 3575 I-lower_bound
) 78 79 3575 3576 O
, 79 80 3576 3577 O
during 81 87 3578 3584 O
the 88 91 3585 3588 O
third 92 97 3589 3594 O
trimester 98 107 3595 3604 O
of 108 110 3605 3607 O
pregnancy 111 120 3608 3617 B-pregnancy

